|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/23/19 MakeMyTrip Ltd 20-F 3/31/19 221:41M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 20-F Annual Report by a Foreign Non-Canadian Issuer HTML 3.13M
2: EX-4.22 Instrument Defining the Rights of Security Holders HTML 134K
3: EX-4.23 Instrument Defining the Rights of Security Holders HTML 68K
4: EX-4.24 Instrument Defining the Rights of Security Holders HTML 70K
5: EX-8.1 Opinion of Counsel re: Tax Matters HTML 63K
8: EX-13.1 Annual or Quarterly Report to Security Holders HTML 62K
9: EX-13.2 Annual or Quarterly Report to Security Holders HTML 62K
6: EX-12.1 Statement re: Computation of Ratios HTML 67K
7: EX-12.2 Statement re: Computation of Ratios HTML 67K
10: EX-15.1 Letter re: Unaudited Interim Financial Info HTML 62K
17: R1 Document and Entity Information HTML 92K
18: R2 Consolidated Statement of Financial Position HTML 173K
19: R3 Consolidated Statement of Profit or Loss and Other HTML 173K
Comprehensive Income (Loss)
20: R4 Consolidated Statement of Changes in Equity HTML 151K
21: R5 Consolidated Statement of Cash Flows HTML 168K
22: R6 Reporting Entity HTML 63K
23: R7 Basis of Accounting HTML 84K
24: R8 Significant Accounting Policies HTML 256K
25: R9 Change in Significant Accounting Policies HTML 399K
26: R10 Determination of Fair Values HTML 80K
27: R11 Financial Risk Management HTML 69K
28: R12 Operating Segments HTML 470K
29: R13 Business Combinations HTML 156K
30: R14 Investment in Equity-Accounted Investees HTML 82K
31: R15 Other Investments HTML 73K
32: R16 Revenue HTML 116K
33: R17 Other Revenue HTML 95K
34: R18 Other Income HTML 86K
35: R19 Personnel Expenses HTML 95K
36: R20 Other Operating Expenses HTML 126K
37: R21 Depreciation, Amortization and Impairment HTML 86K
38: R22 Finance Income and Costs HTML 126K
39: R23 Income Tax Benefit (Expense) HTML 319K
40: R24 Property, Plant and Equipment HTML 537K
41: R25 Intangible Assets and Goodwill HTML 494K
42: R26 Tax Assets and Liabilities HTML 253K
43: R27 Trade and Other Receivables HTML 94K
44: R28 Cash and Cash Equivalents HTML 83K
45: R29 Term Deposits HTML 83K
46: R30 Other Current Assets HTML 87K
47: R31 Assets Held For Sale HTML 74K
48: R32 Other Non-Current Assets HTML 80K
49: R33 Capital and Reserves HTML 153K
50: R34 Loss Per Share HTML 100K
51: R35 Loans and Borrowings HTML 117K
52: R36 Other Current Liabilities HTML 86K
53: R37 Other Non- current Liabilities HTML 79K
54: R38 Deferred Revenue HTML 92K
55: R39 Employee Benefits HTML 360K
56: R40 Share Based Payment HTML 335K
57: R41 Trade and Other Payables HTML 80K
58: R42 Financial Instruments HTML 762K
59: R43 Operating Leases HTML 80K
60: R44 Capital Commitments HTML 61K
61: R45 Related Parties HTML 191K
62: R46 List of Material Subsidiaries HTML 100K
63: R47 Contribution by Non-controlling Interest HTML 61K
64: R48 Change in Classification HTML 65K
65: R49 Contigencies HTML 65K
66: R50 Subsequent Events HTML 66K
67: R51 Quarterly Financial Data (Unaudited) HTML 352K
68: R52 Significant Accounting Policies (Policies) HTML 295K
69: R53 Significant Accounting Policies (Tables) HTML 73K
70: R54 Change in Significant Accounting Policies (Tables) HTML 392K
71: R55 Operating Segments (Tables) HTML 465K
72: R56 Business Combinations (Tables) HTML 146K
73: R57 Investment in Equity-Accounted Investees (Tables) HTML 79K
74: R58 Other Investments (Tables) HTML 71K
75: R59 Revenue (Tables) HTML 111K
76: R60 Other Revenue (Tables) HTML 94K
77: R61 Other Income (Tables) HTML 85K
78: R62 Personnel Expenses (Tables) HTML 95K
79: R63 Other Operating Expenses (Tables) HTML 125K
80: R64 Depreciation, Amortization and Impairment (Tables) HTML 85K
81: R65 Finance Income and Costs (Tables) HTML 125K
82: R66 Income Tax Benefit (Expense) (Tables) HTML 322K
83: R67 Property, Plant and Equipment (Tables) HTML 536K
84: R68 Intangible Assets and Goodwill (Tables) HTML 493K
85: R69 Tax Assets and Liabilities (Tables) HTML 254K
86: R70 Trade and Other Receivables (Tables) HTML 91K
87: R71 Cash and Cash Equivalents (Tables) HTML 81K
88: R72 Term Deposits (Tables) HTML 81K
89: R73 Other Current Assets (Tables) HTML 84K
90: R74 Assets Held For Sale (Tables) HTML 71K
91: R75 Other Non-Current Assets (Tables) HTML 77K
92: R76 Capital and Reserves (Tables) HTML 139K
93: R77 Loss Per Share (Tables) HTML 97K
94: R78 Loans and Borrowings (Tables) HTML 115K
95: R79 Other Current Liabilities (Tables) HTML 84K
96: R80 Other Non- current Liabilities (Tables) HTML 78K
97: R81 Deferred Revenue (Tables) HTML 88K
98: R82 Employee Benefits (Tables) HTML 359K
99: R83 Share Based Payment (Tables) HTML 326K
100: R84 Trade and Other Payables (Tables) HTML 78K
101: R85 Financial Instruments (Tables) HTML 777K
102: R86 Operating Leases (Tables) HTML 78K
103: R87 Related Parties (Tables) HTML 149K
104: R88 List of Material Subsidiaries (Tables) HTML 97K
105: R89 Quarterly Financial Data (Unaudited) (Tables) HTML 351K
106: R90 Significant Accounting Policies - Additional HTML 80K
information (Detail)
107: R91 Significant Accounting Policies - Summary of HTML 73K
Estimated Useful Lives of Assets on Depreciation
Calculated (Detail)
108: R92 Significant Accounting Policies - Summary of HTML 74K
Estimated Useful Lives of Assets on Amortization
of Assets Other than Goodwill Calculated (Detail)
109: R93 Change in Significant Accounting Policies - Impact HTML 68K
of Transition to IFRS 9 on Opening Balances of
Fair Value Reserves and Accumulated Deficit
(Details)
110: R94 Change in Significant Accounting Policies - HTML 109K
Schedule of Original Measurement Categories under
IAS 39 and New Measurement Categories under IFRS 9
for Each Class of Groups Financial Assets
(Details)
111: R95 Change in Significant Accounting Policies - HTML 125K
Summary of Impacts on Consolidated Statement of
Financial Position (Details)
112: R96 Change in Significant Accounting Policies - Impact HTML 120K
on Consolidated Statement of Profit or Loss and
Other Comprehensive Income (Loss) (Details)
113: R97 Change in Significant Accounting Policies - HTML 69K
Additional Information (Detail)
114: R98 Operating Segments - Additional Information HTML 61K
(Detail)
115: R99 Operating Segments - Summary of Reportable HTML 149K
Segments (Detail)
116: R100 Operating Segments - Summary of Reportable HTML 62K
Segments (Detail) (Parenthetical)
117: R101 Operating Segments - Summary of Geographical HTML 91K
Segments (Detail)
118: R102 Business Combinations - Additional Information HTML 151K
(Detail)
119: R103 Business Combinations - Summary of the Acquisition HTML 70K
Date Fair Value of Each Class of Consideration
Transferred (Detail)
120: R104 Business Combinations - Summary of the Acquisition HTML 65K
Date Fair Value of Each Class of Consideration
Transferred (Parenthetical) (Detail)
121: R105 Business Combinations - Summary of Purchase Price HTML 94K
allocation (Detail)
122: R106 Business Combinations - Summary of Purchase Price HTML 64K
allocation (Parenthetical) (Detail)
123: R107 Business Combinations - Summary of Purchase HTML 64K
Consideration (Detail)
124: R108 Investment in Equity-Accounted Investees - Summary HTML 63K
of Financial Information for Individually
Immaterial Associates (Detail)
125: R109 Investment in Equity-Accounted Investees - HTML 76K
Additional Information (Detail)
126: R110 Other Investments - Schedule of Investment HTML 68K
(Detail)
127: R111 Revenue - Additional Information (Detail) HTML 86K
128: R112 Revenue - Schedule of Contract Balances (Detail) HTML 71K
129: R113 Revenue - Schedule of Changes in Contract Assets HTML 67K
(Detail)
130: R114 Other Revenue - Schedule of Other Revenue (Detail) HTML 74K
131: R115 Other Income - Summary of Other Income (Detail) HTML 70K
132: R116 Personnel Expenses - Summary of Personnel expense HTML 75K
(Detail)
133: R117 Other Operating Expenses - Summary of Other HTML 89K
Operating Expenses (Detail)
134: R118 Other Operating Expenses - Summary of Other HTML 63K
Operating Expenses (Parenthetical) (Detail)
135: R119 Depreciation Amortization and Impairment - HTML 71K
Schedule of Depreciation Amortization and
Impairment (Detail)
136: R120 Finance Income and Costs - Summary of Finance HTML 83K
Income and Costs (Detail)
137: R121 Income Tax Benefit (Expense) - Schedule of Income HTML 80K
Tax Recognized in Profit or Loss (Detail)
138: R122 Income Tax Benefit (Expense) - Schedule of Income HTML 104K
Tax Recognized in Other Comprehensive Income
(Detail)
139: R123 Income Tax Benefit (Expense) - Schedule of HTML 116K
Reconciliation of Effective Tax Rate (Detail)
140: R124 Property Plant and Equipment - Summary of Property HTML 156K
Plant and Equipment (Detail)
141: R125 Property Plant and Equipment - Summary of Property HTML 63K
Plant and Equipment (Parenthetical) (Detail)
142: R126 Intangible Assets and Goodwill - Summary of HTML 148K
Intangible Assets and Goodwill (Detail)
143: R127 Intangible Assets and Goodwill - Summary of HTML 68K
Intangible Assets and Goodwill (Parenthetical)
(Detail)
144: R128 Intangible Assets and Goodwill - Summary of HTML 76K
Goodwill has been Allocated to Acquired
Subsidiaries Level (Detail)
145: R129 Intangible Assets and Goodwill - Additional HTML 73K
Information (Detail)
146: R130 Intangible Assets and Goodwill - Summary of HTML 72K
Assumption for Calculation of Cash flow
Projections (Detail)
147: R131 Tax Assets and Liabilities - Summary of HTML 67K
Unrecognized Deferred Tax Assets (Detail)
148: R132 Tax Assets and Liabilities - Additional HTML 70K
Information (Detail)
149: R133 Tax Assets and Liabilities - Summary of Recognized HTML 87K
Deferred Tax Assets and Liabilities (Detail)
150: R134 Tax Assets and Liabilities - Summary of Movement HTML 82K
in Deferred Tax Assets/(Liabilities) (Detail)
151: R135 Trade and Other Receivables - Summary of Trade and HTML 74K
Other Receivables (Detail)
152: R136 Cash and Cash Equivalents - Summary of Cash and HTML 69K
Cash Equivalents (Detail)
153: R137 Term Deposits - Schedule of Term Deposits (Detail) HTML 64K
154: R138 Term Deposits - Additional Information (Detail) HTML 62K
155: R139 Other Current Assets - Summary of Other Current HTML 70K
Assets (Detail)
156: R140 Other Current Assets - Additional Information HTML 62K
(Detail)
157: R141 Other Current Assets - Summary of Other Current HTML 60K
Assets (Parenthetical) (Detail)
158: R142 Assets Held For Sale - Summary of Assets HTML 62K
Classified as Held for Sale (Detail)
159: R143 Other Non-Current Assets - Summary of Other HTML 66K
Non-Current Assets (Detail)
160: R144 Capital and Reserves - Schedule of Share Capital HTML 96K
and Share Premium (Details)
161: R145 Capital and Reserves - Schedule of Share Capital HTML 60K
and Share Premium (Parenthetical) (Details)
162: R146 Capital and Reserves - Additional Information HTML 77K
(Details)
163: R147 Loss Per Share - Computation of Basic and Diluted HTML 70K
Loss Per Share (Detail)
164: R148 Loss Per Share - Additional information (Detail) HTML 63K
165: R149 Loans and Borrowings - Summary of Interest Bearing HTML 67K
Loans and Borrowings Measured At Amortized
Cost/Fair Value (Detail)
166: R150 Loans and Borrowings - Schedule of Terms and HTML 72K
Conditions of Outstanding Loans (Detail)
167: R151 Loans and Borrowings - Additional Information HTML 69K
(Detail)
168: R152 Other Current Liabilities - Summary of Other HTML 70K
Current Liabilities (Detail)
169: R153 Other Non-current Liabilities - Schedule of Other HTML 66K
Non-current Liabilities (Detail)
170: R154 Deferred Revenue - Disclosure of Deferred Revenue HTML 71K
(Detail)
171: R155 Employee Benefits - Summary of Employee Benefits HTML 65K
(Detail)
172: R156 Employee Benefits - Summary of Employee Benefits HTML 63K
(Present Value of Funded Obligation) (Detail)
173: R157 Employee Benefits - Disclosure of Reconciliation HTML 112K
From Opening Balances to Closing Balances For Net
Defined (Asset) Liability and Its Components
(Detail)
174: R158 Employee Benefits - Disclosure of Reconciliation HTML 68K
From Opening Balances to Closing Balances For Net
Defined (Asset) Liability and Its Components
Represented by Associates (Detail)
175: R159 Employee Benefits - Disclosure of Plan Assets HTML 60K
(Detail)
176: R160 Employee Benefits - Summary of Actuarial HTML 70K
Assumptions (Detail)
177: R161 Employee Benefits - Summary of Sensitivity HTML 70K
Analysis for Actuarial Assumptions (Detail)
178: R162 Employee Benefits - Summary of Sensitivity HTML 65K
Analysis for Actuarial Assumptions (Parenthetical)
(Detail)
179: R163 Share Based Payment - Additional Information HTML 158K
(Detail)
180: R164 Share Based Payment - Summary of Number and HTML 110K
Weighted Average Exercise Price of Share Options
(Detail)
181: R165 Share Based Payment - Summary of Terms and HTML 74K
Conditions Relating to Grants under Share
Incentive Plan (Detail)
182: R166 Share Based Payment - Summary of Number and HTML 84K
Weighted Average Exercise Price of Employee Stock
Options under Bona Vita ESOP (Detail)
183: R167 Share Based Payment - Summary of Measurement Used HTML 79K
to Determine Fair Values of Bona Vita ESOP
(Detail)
184: R168 Trade and Other Payables - Summary of Trade and HTML 67K
Other Payables (Detail)
185: R169 Financial Instruments - Summary of Maximum HTML 106K
Exposure to Credit Risk (Detail)
186: R170 Financial Instruments - Summary of Maximum HTML 60K
Exposure to Credit Risk (Parenthetical) (Detail)
187: R171 Financial Instruments - Summary of Age of Trade HTML 75K
and Other Receivables, Term Deposits, Security
Deposits and Contract Assets (Detail)
188: R172 Financial Instruments - Summary of Movement in HTML 70K
Allowance for Impairment in Respect of Trade and
Other Receivables (Detail)
189: R173 Financial Instruments - Summary of Contractual HTML 97K
Maturities of Financial Liabilities, Including
Estimated Interest Payments and Excluding Impact
of Netting Agreements (Detail)
190: R174 Financial Instruments - Summary of Currency Risk HTML 69K
(Detail)
191: R175 Financial Instruments - Summary of Significant HTML 63K
Exchange Rates Applied (Detail)
192: R176 Financial Instruments - Additional Information HTML 74K
(Detail)
193: R177 Financial Instruments - Sensitivity Analysis of HTML 62K
Exchange Rate (Detail)
194: R178 Financial Instruments - Summary of HTML 71K
Interest-Bearing Financial instruments (Detail)
195: R179 Financial Instruments - Summary of HTML 61K
Interest-Bearing Financial instruments
(Parenthetical) (Detail)
196: R180 Financial Instruments - Summary of Fair Values of HTML 123K
Financial Assets and Liabilities (Detail)
197: R181 Financial Instruments - Summary of Financial HTML 72K
Instruments Carried at Fair Value (Detail)
198: R182 Financial Instruments - Summary of Reconciliation HTML 81K
Fair Value Measurements in Level 3 of Fair Value
Hierarchy (Detail)
199: R183 Financial Instruments - Summary of Financial HTML 73K
Instruments Measured at Fair Value (Detail)
200: R184 Financial Instruments - Summary of Financial HTML 82K
Instruments Measured at Fair Value (Parenthetical)
(Detail)
201: R185 Financial Instruments - Summary of Financial HTML 63K
Instruments Not Measured at Fair Value (Detail)
202: R186 Financial Instruments - Summary of Sensitivity HTML 70K
Analysis For Other Investments (Detail)
203: R187 Financial Instruments - Summary of Receivable from HTML 65K
Related Party (Detail)
204: R188 Financial Instruments - Summary of Right to HTML 63K
Receive Equity Stake in Travel Entity (Detail)
205: R189 Operating Leases - Summary of Non-cancellable HTML 68K
Operating Lease Rentals Payables (Detail)
206: R190 Operating Leases - Additional Information (Detail) HTML 66K
207: R191 Capital Commitments - Additional Information HTML 60K
(Detail)
208: R192 Related Parties - Summary of Key Management HTML 70K
Personnel Compensation (Detail)
209: R193 Related Parties - Additional Information (Detail) HTML 120K
210: R194 Related Parties - Summary of Transaction with HTML 62K
Entity Providing Key Management Personnel Services
(Detail)
211: R195 Related Parties - Summary of Transactions With HTML 65K
Subsidiary of Entity Having Significant Influence
Over the Company (Detail)
212: R196 Related Parties - Summary of Transactions with HTML 68K
Equity-Accounted Investee and Its Subsidiaries
(Detail)
213: R197 List of Material Subsidiaries - Schedule of List HTML 92K
of Material Subsidiaries (Detail)
214: R198 Contribution by Non-controlling Interest - HTML 67K
Additional Information (Detail)
215: R199 Change in Classification - Additional Information HTML 68K
(Detail)
216: R200 Contigencies - Additional Information (Detail) HTML 60K
217: R201 Subsequent Events - Additional Information HTML 85K
(Details)
218: R202 Quarterly Financial Data (Unaudited) - Summary of HTML 110K
Quarterly Financial Data (Detail)
220: XML IDEA XML File -- Filing Summary XML 436K
219: EXCEL IDEA Workbook of Financial Reports XLSX 249K
11: EX-101.INS XBRL Instance -- mmyt-20190331 XML 13.71M
13: EX-101.CAL XBRL Calculations -- mmyt-20190331_cal XML 481K
14: EX-101.DEF XBRL Definitions -- mmyt-20190331_def XML 1.66M
15: EX-101.LAB XBRL Labels -- mmyt-20190331_lab XML 2.92M
16: EX-101.PRE XBRL Presentations -- mmyt-20190331_pre XML 2.46M
12: EX-101.SCH XBRL Schema -- mmyt-20190331 XSD 650K
221: ZIP XBRL Zipped Folder -- 0001564590-19-025532-xbrl Zip 540K
Exhibit 12.2
Certification of Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Mohit Kabra, certify that:
|
1. |
I have reviewed this annual report on Form 20-F of MakeMyTrip Limited (the “Company”); |
|
2. |
Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report; |
|
4. |
The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the company and have: |
|
|
a) |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b) |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c) |
evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d) |
disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company’s internal control over financial reporting. |
|
5. |
The company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the Audit Committee of the company’s Board of Directors (or persons performing the equivalent functions): |
|
|
a) |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report financial information; and |
|
|
b) |
any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting. |
|
Date: July 23, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Mohit Kabra |
|
|
|
Name: |
|
|
|
|
|
Title: |
|
Group Chief Financial Officer |
| This ‘20-F’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 7/23/19 | |||
| For Period end: | 3/31/19 | 6-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/08/23 NaaS Technology Inc. CORRESP¶ 5/18/23 1:75K Donnelley … Solutions/FA 8/19/20 SEC UPLOAD¶ 9/17/20 2:39K MakeMyTrip Ltd. 8/17/20 MakeMyTrip Ltd. 20-F 3/31/20 215:43M ActiveDisclosure/FA 3/25/20 SEC UPLOAD¶ 9/17/20 2:49K MakeMyTrip Ltd. |